| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.716 | 0.008 | 0.74 | Aryl hydrocarbon receptor agonist | 0.379 0.041 CID_107705 0.733 0.008 CID_105022 0.733 0.008 CID_104988 0.74 0.008 CID_104936 | CID_104936 | |
| 0.634 | 0.032 | 0.774 | Caspase 9 stimulant | 0.74 0.019 CID_107705 0.774 0.015 CID_105022 0.774 0.015 CID_104988 0.766 0.016 CID_104936 | CID_104988 | |
| 0.574 | 0.005 | 0.59 | Mcl-1 antagonist | 0.261 0.032 CID_107705 0.59 0.004 CID_105022 0.59 0.004 CID_104988 0.574 0.005 CID_104936 | CID_104988 | |
| 0.527 | 0.011 | 0.527 | Superoxide dismutase inhibitor | 0.302 0.05 CID_107705 0.492 0.014 CID_105022 0.492 0.014 CID_104988 0.458 0.018 CID_104936 | ||
| 0.515 | 0.008 | 0.589 | Sigma receptor agonist | 0.589 0.005 CID_107705 0.345 0.031 CID_105022 0.345 0.031 CID_104988 0.279 0.043 CID_104936 | CID_107705 | |
| 0.525 | 0.024 | 0.525 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.416 0.087 CID_107705 0.432 0.074 CID_105022 0.432 0.074 CID_104988 0.402 0.098 CID_104936 | ||
| 0.503 | 0.026 | 0.503 | Calcium channel L-type activator | 0.41 0.074 CID_107705 0.473 0.039 CID_105022 0.473 0.039 CID_104988 0.485 0.034 CID_104936 | ||
| 0.504 | 0.028 | 0.504 | Thioredoxin glutathione reductase inhibitor | 0.497 0.029 CID_107705 0.432 0.045 CID_105022 0.432 0.045 CID_104988 0.428 0.047 CID_104936 | ||
| 0.536 | 0.064 | 0.715 | Apoptosis agonist | 0.715 0.028 CID_107705 0.642 0.041 CID_105022 0.642 0.041 CID_104988 0.64 0.041 CID_104936 | CID_107705 | |
| 0.491 | 0.021 | 0.62 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.337 0.054 CID_107705 0.607 0.009 CID_105022 0.607 0.009 CID_104988 0.62 0.008 CID_104936 | CID_104936 | |
| 0.469 | 0.005 | 0.469 | DNA intercalator | 0.217 0.021 CID_107705 0.43 0.007 CID_105022 0.43 0.007 CID_104988 0.422 0.007 CID_104936 | ||
| 0.466 | 0.009 | 0.466 | Calcium channel activator | 0.402 0.024 CID_107705 0.408 0.022 CID_105022 0.408 0.022 CID_104988 0.425 0.017 CID_104936 | ||
| 0.478 | 0.03 | 0.478 | Calpain 2 inhibitor | 0.291 0.12 CID_107705 0.427 0.047 CID_105022 0.427 0.047 CID_104988 0.437 0.043 CID_104936 | ||
| 0.471 | 0.035 | 0.527 | GABA C receptor rho-3 antagonist | 0.286 0.125 CID_107705 0.527 0.019 CID_105022 0.527 0.019 CID_104988 0.526 0.019 CID_104936 | CID_104988 | |
| 0.468 | 0.033 | 0.517 | Streptokinase A inhibitor | 0.191 0.139 CID_107705 0.517 0.026 CID_105022 0.517 0.026 CID_104988 0.509 0.027 CID_104936 | CID_104988 | |
| 0.46 | 0.038 | 0.46 | Vasodilator, peripheral | 0.348 0.074 CID_107705 0.43 0.046 CID_105022 0.43 0.046 CID_104988 0.422 0.048 CID_104936 | ||
| 0.427 | 0.023 | 0.494 | DNA damaging | 0.494 0.014 CID_107705 0.492 0.014 CID_105022 0.492 0.014 CID_104988 0.477 0.016 CID_104936 | CID_107705 | |
| 0.414 | 0.023 | 0.414 | Interleukin 2 agonist | 0.342 0.049 CID_107705 0.381 0.033 CID_105022 0.381 0.033 CID_104988 0.359 0.042 CID_104936 | ||
| 0.387 | 0.008 | 0.543 | Interleukin 6 antagonist | 0.543 0.004 CID_107705 0.347 0.01 CID_105022 0.347 0.01 CID_104988 0.402 0.007 CID_104936 | CID_107705 | |
| 0.429 | 0.058 | 0.51 | Prostaglandin dehydrogenase inhibitor | 0.22 0.144 CID_107705 0.51 0.04 CID_105022 0.51 0.04 CID_104988 0.501 0.041 CID_104936 | CID_104988 | |
| 0.42 | 0.065 | 0.467 | Histamine release inhibitor | 0.293 0.127 CID_107705 0.467 0.042 CID_105022 0.467 0.042 CID_104988 0.458 0.046 CID_104936 | CID_104988 | |
| 0.392 | 0.041 | 0.604 | 12-Lipoxygenase inhibitor | 0.227 0.124 CID_107705 0.604 0.013 CID_105022 0.604 0.013 CID_104988 0.578 0.015 CID_104936 | CID_104988 | |
| 0.353 | 0.006 | 0.353 | Toll-Like receptor 9 antagonist | 0.224 0.027 CID_107705 0.283 0.015 CID_105022 0.283 0.015 CID_104988 0.26 0.019 CID_104936 | ||
| 0.385 | 0.04 | 0.385 | Vasodilator, coronary | 0.379 0.043 CID_107705 0.372 0.045 CID_105022 0.372 0.045 CID_104988 0.363 0.049 CID_104936 | ||
| 0.345 | 0.004 | 0.367 | Mannose-6-phosphate isomerase inhibitor | 0.264 0.009 CID_107705 0.349 0.004 CID_105022 0.349 0.004 CID_104988 0.367 0.004 CID_104936 | CID_104936 | |
| 0.332 | 0.009 | 0.38 | M18 aspartyl aminopeptidase inhibitor | 0.181 0.039 CID_107705 0.38 0.005 CID_105022 0.38 0.005 CID_104988 0.378 0.006 CID_104936 | CID_104988 | |
| 0.422 | 0.101 | 0.422 | Transcription factor inhibitor | 0.296 0.157 CID_107705 0.401 0.109 CID_105022 0.401 0.109 CID_104988 0.398 0.11 CID_104936 | ||
| 0.352 | 0.033 | 0.352 | Vasodilator | 0.265 0.061 CID_107705 0.334 0.038 CID_105022 0.334 0.038 CID_104988 0.304 0.047 CID_104936 | ||
| 0.325 | 0.01 | 0.341 | Histone acetyltransferase inhibitor | 0.211 0.054 CID_107705 0.341 0.008 CID_105022 0.341 0.008 CID_104988 0.318 0.011 CID_104936 | CID_104988 | |
| 0.341 | 0.03 | 0.477 | Peroxidase inhibitor | 0.142 0.082 CID_107705 0.477 0.012 CID_105022 0.477 0.012 CID_104988 0.402 0.02 CID_104936 | CID_104988 | |
| 0.317 | 0.009 | 0.317 | Glutamate receptor antagonist | 0.206 0.024 CID_105022 0.206 0.024 CID_104988 0.2 0.026 CID_104936 | ||
| 0.309 | 0.009 | 0.309 | 3C-like protease (Human coronavirus) inhibitor | 0.203 0.05 CID_107705 0.222 0.04 CID_105022 0.222 0.04 CID_104988 0.203 0.05 CID_104936 | ||
| 0.301 | 0.01 | 0.301 | Succinate dehydrogenase inhibitor | 0.244 0.025 CID_107705 0.301 0.01 CID_105022 0.301 0.01 CID_104988 0.274 0.016 CID_104936 | ||
| 0.3 | 0.01 | 0.3 | UDP-glucose 4-epimerase inhibitor | 0.241 0.014 CID_107705 0.293 0.011 CID_105022 0.293 0.011 CID_104988 0.266 0.012 CID_104936 | ||
| 0.292 | 0.004 | 0.292 | Sphingosine 1-phosphate receptor 4 antagonist | 0.179 0.015 CID_107705 0.241 0.005 CID_105022 0.241 0.005 CID_104988 0.246 0.005 CID_104936 | ||
| 0.309 | 0.021 | 0.375 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.218 0.059 CID_107705 0.375 0.009 CID_105022 0.375 0.009 CID_104988 0.375 0.009 CID_104936 | CID_104936 | |
| 0.404 | 0.117 | 0.412 | DNA polymerase beta inhibitor | 0.258 0.187 CID_107705 0.412 0.114 CID_105022 0.412 0.114 CID_104988 0.406 0.117 CID_104936 | CID_104988 | |
| 0.291 | 0.012 | 0.363 | Hexokinase inhibitor | 0.18 0.049 CID_107705 0.357 0.005 CID_105022 0.357 0.005 CID_104988 0.363 0.005 CID_104936 | CID_104936 | |
| 0.289 | 0.014 | 0.312 | Nitric-oxide synthase stimulant | 0.256 0.029 CID_107705 0.303 0.01 CID_105022 0.303 0.01 CID_104988 0.312 0.009 CID_104936 | CID_104936 | |
| 0.281 | 0.007 | 0.281 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.205 0.015 CID_107705 0.216 0.013 CID_105022 0.216 0.013 CID_104988 0.201 0.015 CID_104936 | ||
| 0.288 | 0.016 | 0.444 | Heat shock protein 90 alpha antagonist | 0.265 0.022 CID_107705 0.438 0.005 CID_105022 0.438 0.005 CID_104988 0.444 0.005 CID_104936 | CID_104936 | |
| 0.311 | 0.043 | 0.311 | Interleukin agonist | 0.229 0.095 CID_107705 0.301 0.048 CID_105022 0.301 0.048 CID_104988 0.276 0.061 CID_104936 | ||
| 0.271 | 0.004 | 0.376 | CD45 antagonist | 0.079 0.012 CID_107705 0.376 0.003 CID_105022 0.376 0.003 CID_104988 0.313 0.004 CID_104936 | CID_104988 | |
| 0.314 | 0.047 | 0.388 | Transcription factor STAT3 inhibitor | 0.203 0.129 CID_107705 0.378 0.024 CID_105022 0.378 0.024 CID_104988 0.388 0.021 CID_104936 | CID_104936 | |
| 0.295 | 0.029 | 0.345 | Dual specificity phosphatase 3 inhibitor | 0.127 0.12 CID_107705 0.345 0.021 CID_105022 0.345 0.021 CID_104988 0.336 0.023 CID_104936 | CID_104988 | |
| 0.299 | 0.034 | 0.307 | Tyrosine 3 hydroxylase inhibitor | 0.209 0.12 CID_107705 0.307 0.03 CID_105022 0.307 0.03 CID_104988 0.301 0.033 CID_104936 | CID_104988 | |
| 0.312 | 0.047 | 0.34 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.34 0.038 CID_105022 0.34 0.038 CID_104988 0.329 0.041 CID_104936 | CID_104988 | |
| 0.386 | 0.121 | 0.413 | DNA directed DNA polymerase inhibitor | 0.26 0.186 CID_107705 0.413 0.11 CID_105022 0.413 0.11 CID_104988 0.402 0.115 CID_104936 | CID_104988 | |
| 0.313 | 0.049 | 0.392 | Transcription factor STAT inhibitor | 0.182 0.165 CID_107705 0.383 0.023 CID_105022 0.383 0.023 CID_104988 0.392 0.021 CID_104936 | CID_104936 | |
| 0.267 | 0.007 | 0.299 | Porphobilinogen synthase inhibitor | 0.095 0.038 CID_107705 0.299 0.005 CID_105022 0.299 0.005 CID_104988 0.265 0.007 CID_104936 | CID_104988 | |
| 0.266 | 0.006 | 0.266 | Triose-phosphate isomerase inhibitor | 0.161 0.017 CID_107705 0.218 0.009 CID_105022 0.218 0.009 CID_104988 0.189 0.012 CID_104936 | ||
| 0.269 | 0.015 | 0.269 | Interleukin 1 antagonist | 0.149 0.058 CID_107705 0.223 0.025 CID_105022 0.223 0.025 CID_104988 0.237 0.021 CID_104936 | ||
| 0.288 | 0.038 | 0.288 | 5 Hydroxytryptamine 1E antagonist | 0.193 0.139 CID_107705 0.263 0.061 CID_105022 0.263 0.061 CID_104988 0.263 0.061 CID_104936 | ||
| 0.281 | 0.034 | 0.333 | DNA methyltransferase I inhibitor | 0.153 0.1 CID_107705 0.333 0.017 CID_105022 0.333 0.017 CID_104988 0.311 0.022 CID_104936 | CID_104988 | |
| 0.356 | 0.11 | 0.356 | 5 Hydroxytryptamine release inhibitor | 0.303 0.162 CID_105022 0.303 0.162 CID_104988 0.309 0.155 CID_104936 | ||
| 0.295 | 0.054 | 0.315 | Dyrk kinase inhibitor | 0.315 0.047 CID_105022 0.315 0.047 CID_104988 0.304 0.051 CID_104936 | CID_104988 | |
| 0.287 | 0.047 | 0.305 | Cyclic AMP phosphodiesterase inhibitor | 0.229 0.075 CID_107705 0.305 0.04 CID_105022 0.305 0.04 CID_104988 0.304 0.04 CID_104936 | CID_104988 | |
| 0.29 | 0.05 | 0.407 | Pyruvate kinase inhibitor | 0.407 0.019 CID_105022 0.407 0.019 CID_104988 0.404 0.02 CID_104936 | CID_104988 | |
| 0.251 | 0.012 | 0.251 | Interleukin 1b antagonist | 0.111 0.07 CID_107705 0.181 0.024 CID_105022 0.181 0.024 CID_104988 0.159 0.034 CID_104936 | ||
| 0.243 | 0.005 | 0.303 | Alcohol oxidase inhibitor | 0.097 0.019 CID_107705 0.303 0.004 CID_105022 0.303 0.004 CID_104988 0.212 0.006 CID_104936 | CID_104988 | |
| 0.245 | 0.01 | 0.289 | NMDA receptor antagonist | 0.082 0.063 CID_107705 0.289 0.007 CID_105022 0.289 0.007 CID_104988 0.271 0.008 CID_104936 | CID_104988 | |
| 0.243 | 0.009 | 0.243 | Calcium antagonist | 0.148 0.023 CID_107705 0.147 0.023 CID_105022 0.147 0.023 CID_104988 0.125 0.032 CID_104936 | ||
| 0.248 | 0.017 | 0.347 | Alkylator | 0.34 0.01 CID_107705 0.347 0.01 CID_105022 0.347 0.01 CID_104988 0.344 0.01 CID_104936 | CID_104988 | |
| 0.262 | 0.035 | 0.405 | Dual specificity phosphatase inhibitor | 0.386 0.016 CID_105022 0.386 0.016 CID_104988 0.405 0.014 CID_104936 | CID_104936 | |
| 0.359 | 0.132 | 0.47 | Alpha-glucosidase inhibitor | 0.265 0.179 CID_107705 0.47 0.089 CID_105022 0.47 0.089 CID_104988 0.461 0.092 CID_104936 | CID_104988 | |
| 0.272 | 0.046 | 0.272 | Calpain inhibitor | 0.171 0.148 CID_107705 0.248 0.067 CID_105022 0.248 0.067 CID_104988 0.253 0.062 CID_104936 | ||
| 0.231 | 0.007 | 0.254 | HIV-1 integrase (Overall Integration) inhibitor | 0.16 0.022 CID_107705 0.246 0.005 CID_105022 0.246 0.005 CID_104988 0.254 0.005 CID_104936 | CID_104936 | |
| 0.241 | 0.018 | 0.241 | Toll-Like receptor antagonist | 0.122 0.081 CID_107705 0.186 0.036 CID_105022 0.186 0.036 CID_104988 0.168 0.044 CID_104936 | ||
| 0.243 | 0.023 | 0.383 | Heat shock protein 90 antagonist | 0.226 0.028 CID_107705 0.377 0.005 CID_105022 0.377 0.005 CID_104988 0.383 0.005 CID_104936 | CID_104936 | |
| 0.243 | 0.031 | 0.243 | Cytidine deaminase inhibitor | 0.118 0.102 CID_107705 0.172 0.061 CID_105022 0.172 0.061 CID_104988 0.174 0.06 CID_104936 | ||
| 0.223 | 0.012 | 0.223 | Adenylate kinase inhibitor | 0.149 0.027 CID_107705 0.176 0.019 CID_105022 0.176 0.019 CID_104988 0.173 0.02 CID_104936 | ||
| 0.245 | 0.035 | 0.255 | Amyloid beta precursor protein antagonist | 0.255 0.031 CID_105022 0.255 0.031 CID_104988 0.246 0.034 CID_104936 | CID_104988 | |
| 0.327 | 0.116 | 0.433 | Antibacterial | 0.406 0.074 CID_107705 0.433 0.063 CID_105022 0.433 0.063 CID_104988 0.418 0.069 CID_104936 | CID_104988 | |
| 0.214 | 0.009 | 0.374 | Creatine kinase inhibitor | 0.157 0.021 CID_107705 0.374 0.003 CID_105022 0.374 0.003 CID_104988 0.336 0.004 CID_104936 | CID_104988 | |
| 0.28 | 0.076 | 0.397 | Hypoxia-inducible factor 1 alpha inhibitor | 0.283 0.074 CID_107705 0.393 0.032 CID_105022 0.393 0.032 CID_104988 0.397 0.031 CID_104936 | CID_104936 | |
| 0.209 | 0.009 | 0.38 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.145 0.02 CID_107705 0.346 0.004 CID_105022 0.346 0.004 CID_104988 0.38 0.003 CID_104936 | CID_104936 | |
| 0.249 | 0.049 | 0.301 | DNA methylase inhibitor | 0.137 0.13 CID_107705 0.301 0.028 CID_105022 0.301 0.028 CID_104988 0.277 0.035 CID_104936 | CID_104988 | |
| 0.227 | 0.03 | 0.227 | 5 Hydroxytryptamine 3E antagonist | 0.179 0.109 CID_107705 0.172 0.128 CID_105022 0.172 0.128 CID_104988 0.17 0.135 CID_104936 | ||
| 0.223 | 0.028 | 0.223 | Alpha-N-acetylglucosaminidase inhibitor | 0.139 0.062 CID_107705 0.172 0.044 CID_105022 0.172 0.044 CID_104988 0.172 0.044 CID_104936 | ||
| 0.227 | 0.033 | 0.243 | Glycogen synthase kinase-3 alpha inhibitor | 0.234 0.031 CID_105022 0.234 0.031 CID_104988 0.243 0.028 CID_104936 | CID_104936 | |
| 0.24 | 0.047 | 0.282 | Non-steroidal antiinflammatory agent | 0.214 0.061 CID_107705 0.276 0.034 CID_105022 0.276 0.034 CID_104988 0.282 0.032 CID_104936 | CID_104936 | |
| 0.215 | 0.022 | 0.235 | Catenin beta inhibitor | 0.235 0.014 CID_105022 0.235 0.014 CID_104988 0.229 0.016 CID_104936 | CID_104988 | |
| 0.262 | 0.07 | 0.262 | 5 Hydroxytryptamine uptake stimulant | 0.216 0.123 CID_107705 0.233 0.099 CID_105022 0.233 0.099 CID_104988 0.231 0.102 CID_104936 | ||
| 0.196 | 0.009 | 0.196 | Thioredoxin inhibitor | 0.122 0.029 CID_107705 0.19 0.009 CID_105022 0.19 0.009 CID_104988 0.183 0.01 CID_104936 | ||
| 0.194 | 0.008 | 0.256 | DOPA decarboxylase inhibitor | 0.134 0.032 CID_107705 0.256 0.004 CID_105022 0.256 0.004 CID_104988 0.238 0.004 CID_104936 | CID_104988 | |
| 0.204 | 0.019 | 0.234 | CF transmembrane conductance regulator agonist | 0.149 0.077 CID_107705 0.226 0.011 CID_105022 0.226 0.011 CID_104988 0.234 0.009 CID_104936 | CID_104936 | |
| 0.202 | 0.017 | 0.202 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.132 0.112 CID_107705 0.194 0.022 CID_105022 0.194 0.022 CID_104988 0.19 0.024 CID_104936 | ||
| 0.212 | 0.029 | 0.234 | M17 leucyl aminopeptidase inhibitor | 0.234 0.024 CID_107705 0.167 0.046 CID_105022 0.167 0.046 CID_104988 0.177 0.041 CID_104936 | CID_107705 | |
| 0.186 | 0.005 | 0.274 | NMDA receptor subunit 3B antagonist | 0.051 0.024 CID_107705 0.274 0.004 CID_105022 0.274 0.004 CID_104988 0.243 0.004 CID_104936 | CID_104988 | |
| 0.203 | 0.022 | 0.203 | Cathepsin H inhibitor | 0.167 0.035 CID_107705 0.143 0.052 CID_105022 0.143 0.052 CID_104988 0.135 0.058 CID_104936 | ||
| 0.202 | 0.022 | 0.202 | Ferrochelatase inhibitor | 0.087 0.086 CID_107705 0.097 0.074 CID_105022 0.097 0.074 CID_104988 0.088 0.086 CID_104936 | ||
| 0.183 | 0.005 | 0.183 | Thioredoxin reductase inhibitor | 0.165 0.007 CID_107705 0.166 0.007 CID_105022 0.166 0.007 CID_104988 0.152 0.009 CID_104936 | ||
| 0.213 | 0.036 | 0.269 | NOS3 expression enhancer | 0.124 0.108 CID_107705 0.269 0.023 CID_105022 0.269 0.023 CID_104988 0.239 0.029 CID_104936 | CID_104988 | |
| 0.184 | 0.007 | 0.184 | Biliverdin reductase inhibitor | 0.101 0.018 CID_107705 0.127 0.012 CID_105022 0.127 0.012 CID_104988 0.114 0.015 CID_104936 | ||
| 0.252 | 0.077 | 0.252 | Gastrin inhibitor | 0.193 0.16 CID_105022 0.193 0.16 CID_104988 0.202 0.146 CID_104936 | ||
| 0.18 | 0.005 | 0.18 | NMDA 2C receptor antagonist | 0.071 0.032 CID_107705 0.168 0.006 CID_105022 0.168 0.006 CID_104988 0.157 0.006 CID_104936 | ||
| 0.188 | 0.014 | 0.271 | Alcohol dehydrogenase inhibitor | 0.093 0.06 CID_107705 0.265 0.007 CID_105022 0.265 0.007 CID_104988 0.271 0.006 CID_104936 | CID_104936 | |
| 0.176 | 0.004 | 0.176 | Bcl2 antagonist | 0.106 0.015 CID_107705 0.14 0.006 CID_105022 0.14 0.006 CID_104988 0.128 0.008 CID_104936 | ||
| 0.232 | 0.063 | 0.282 | RNA-directed DNA polymerase inhibitor | 0.187 0.119 CID_107705 0.277 0.037 CID_105022 0.277 0.037 CID_104988 0.282 0.036 CID_104936 | CID_104936 | |
| 0.189 | 0.02 | 0.189 | MAP3K9 inhibitor | 0.145 0.068 CID_107705 0.169 0.036 CID_105022 0.169 0.036 CID_104988 0.165 0.041 CID_104936 | ||
| 0.198 | 0.031 | 0.198 | Calcium channel blocker | 0.111 0.098 CID_105022 0.111 0.098 CID_104988 | ||
| 0.171 | 0.003 | 0.171 | Kainate receptor 5 antagonist | 0.038 0.007 CID_107705 0.053 0.005 CID_105022 0.053 0.005 CID_104988 0.057 0.005 CID_104936 | ||
| 0.169 | 0.003 | 0.177 | Catechol O-methyltransferase inhibitor | 0.081 0.005 CID_107705 0.171 0.003 CID_105022 0.171 0.003 CID_104988 0.177 0.003 CID_104936 | CID_104936 | |
| 0.249 | 0.083 | 0.573 | Aldehyde oxidase inhibitor | 0.517 0.03 CID_105022 0.517 0.03 CID_104988 0.573 0.023 CID_104936 | CID_104936 | |
| 0.184 | 0.019 | 0.264 | Carbonic anhydrase III inhibitor | 0.121 0.043 CID_107705 0.264 0.008 CID_105022 0.264 0.008 CID_104988 0.232 0.011 CID_104936 | CID_104988 | |
| 0.274 | 0.11 | 0.385 | Transcription factor NF kappa B inhibitor | 0.265 0.117 CID_107705 0.385 0.067 CID_105022 0.385 0.067 CID_104988 0.38 0.068 CID_104936 | CID_104988 | |
| 0.178 | 0.016 | 0.178 | TRPA1 agonist | 0.112 0.069 CID_107705 0.176 0.017 CID_105022 0.176 0.017 CID_104988 0.165 0.022 CID_104936 | ||
| 0.197 | 0.036 | 0.22 | Neurotensin receptor agonist | 0.144 0.117 CID_107705 0.22 0.027 CID_105022 0.22 0.027 CID_104988 0.211 0.03 CID_104936 | CID_104988 | |
| 0.169 | 0.008 | 0.187 | Interleukin 12 antagonist | 0.105 0.047 CID_107705 0.161 0.01 CID_105022 0.161 0.01 CID_104988 0.187 0.006 CID_104936 | CID_104936 | |
| 0.178 | 0.02 | 0.178 | Interleukin 8 antagonist | 0.157 0.03 CID_105022 0.157 0.03 CID_104988 0.165 0.026 CID_104936 | ||
| 0.176 | 0.019 | 0.184 | Photosensitizer | 0.131 0.045 CID_107705 0.169 0.022 CID_105022 0.169 0.022 CID_104988 0.184 0.017 CID_104936 | CID_104936 | |
| 0.173 | 0.017 | 0.256 | Beta glucuronidase inhibitor | 0.133 0.035 CID_107705 0.256 0.008 CID_105022 0.256 0.008 CID_104988 0.23 0.01 CID_104936 | CID_104988 | |
| 0.245 | 0.091 | 0.245 | 5 Hydroxytryptamine release stimulant | 0.172 0.15 CID_107705 0.169 0.153 CID_105022 0.169 0.153 CID_104988 0.175 0.146 CID_104936 | ||
| 0.159 | 0.005 | 0.159 | AMPA receptor antagonist | 0.044 0.037 CID_107705 0.132 0.007 CID_105022 0.132 0.007 CID_104988 0.121 0.008 CID_104936 | ||
| 0.161 | 0.009 | 0.161 | Calcium channel L-type blocker | 0.083 0.037 CID_107705 0.096 0.027 CID_105022 0.096 0.027 CID_104988 0.087 0.033 CID_104936 | ||
| 0.178 | 0.025 | 0.178 | GABA C receptor agonist | 0.149 0.034 CID_105022 0.149 0.034 CID_104988 0.149 0.034 CID_104936 | ||
| 0.167 | 0.017 | 0.302 | Histidine decarboxylase inhibitor | 0.105 0.03 CID_107705 0.269 0.008 CID_105022 0.269 0.008 CID_104988 0.302 0.006 CID_104936 | CID_104936 | |
| 0.231 | 0.081 | 0.282 | DNA synthesis inhibitor | 0.21 0.109 CID_107705 0.282 0.05 CID_105022 0.282 0.05 CID_104988 0.263 0.059 CID_104936 | CID_104988 | |
| 0.153 | 0.005 | 0.195 | D-Ala-D-Ala ligase inhibitor | 0.109 0.021 CID_107705 0.195 0.003 CID_105022 0.195 0.003 CID_104988 0.186 0.004 CID_104936 | CID_104988 | |
| 0.192 | 0.044 | 0.217 | ATPase inhibitor | 0.217 0.026 CID_107705 0.211 0.029 CID_105022 0.211 0.029 CID_104988 0.197 0.04 CID_104936 | CID_107705 | |
| 0.181 | 0.033 | 0.247 | Aldehyde dehydrogenase inhibitor | 0.105 0.09 CID_107705 0.247 0.018 CID_105022 0.247 0.018 CID_104988 0.221 0.023 CID_104936 | CID_104988 | |
| 0.174 | 0.029 | 0.174 | Sphingosine 1-phosphate receptor 5 antagonist | 0.156 0.052 CID_105022 0.156 0.052 CID_104988 0.163 0.042 CID_104936 | ||
| 0.168 | 0.022 | 0.277 | Potassium channel (Ca-activated) activator | 0.277 0.006 CID_105022 0.277 0.006 CID_104988 0.268 0.006 CID_104936 | CID_104988 | |
| 0.184 | 0.04 | 0.228 | Alkaline phosphatase inhibitor | 0.228 0.025 CID_105022 0.228 0.025 CID_104988 0.213 0.029 CID_104936 | CID_104988 | |
| 0.162 | 0.018 | 0.169 | Urease inhibitor | 0.116 0.049 CID_107705 0.169 0.015 CID_105022 0.169 0.015 CID_104988 0.167 0.016 CID_104936 | CID_104988 | |
| 0.183 | 0.04 | 0.197 | GABA C receptor rho-2 antagonist | 0.19 0.035 CID_105022 0.19 0.035 CID_104988 0.197 0.03 CID_104936 | CID_104936 | |
| 0.164 | 0.024 | 0.169 | Protein kinase C gamma inhibitor | 0.104 0.07 CID_107705 0.154 0.029 CID_105022 0.154 0.029 CID_104988 0.169 0.022 CID_104936 | CID_104936 | |
| 0.208 | 0.069 | 0.242 | Neurotrophic factor enhancer | 0.165 0.116 CID_107705 0.242 0.043 CID_105022 0.242 0.043 CID_104988 0.224 0.056 CID_104936 | CID_104988 | |
| 0.17 | 0.035 | 0.268 | Interleukin 4 antagonist | 0.158 0.043 CID_107705 0.258 0.012 CID_105022 0.258 0.012 CID_104988 0.268 0.011 CID_104936 | CID_104936 | |
| 0.249 | 0.113 | 0.472 | Caspase 3 stimulant | 0.472 0.025 CID_107705 0.425 0.037 CID_105022 0.425 0.037 CID_104988 0.409 0.042 CID_104936 | CID_107705 | |
| 0.14 | 0.005 | 0.205 | NMDA receptor subunit 3A antagonist | 0.038 0.027 CID_107705 0.205 0.004 CID_105022 0.205 0.004 CID_104988 0.188 0.004 CID_104936 | CID_104988 | |
| 0.158 | 0.024 | 0.158 | Catalase inhibitor | 0.065 0.059 CID_107705 0.14 0.028 CID_105022 0.14 0.028 CID_104988 0.119 0.033 CID_104936 | ||
| 0.136 | 0.003 | 0.136 | NMDA 2D receptor antagonist | 0.051 0.007 CID_107705 0.075 0.005 CID_105022 0.075 0.005 CID_104988 0.067 0.005 CID_104936 | ||
| 0.148 | 0.017 | 0.157 | NMDA 2 receptor antagonist | 0.157 0.015 CID_105022 0.157 0.015 CID_104988 0.135 0.02 CID_104936 | CID_104988 | |
| 0.135 | 0.003 | 0.135 | Kainate receptor 4 antagonist | 0.051 0.007 CID_107705 0.063 0.005 CID_105022 0.063 0.005 CID_104988 0.064 0.005 CID_104936 | ||
| 0.173 | 0.043 | 0.232 | NADPH oxidase inhibitor | 0.232 0.025 CID_105022 0.232 0.025 CID_104988 0.229 0.026 CID_104936 | CID_104988 | |
| 0.164 | 0.035 | 0.302 | Cystathionine beta-synthase inhibitor | 0.119 0.059 CID_107705 0.302 0.009 CID_105022 0.302 0.009 CID_104988 0.28 0.011 CID_104936 | CID_104988 | |
| 0.163 | 0.034 | 0.22 | Alpha 2b adrenoreceptor antagonist | 0.22 0.02 CID_107705 0.143 0.042 CID_105022 0.143 0.042 CID_104988 0.151 0.038 CID_104936 | CID_107705 | |
| 0.202 | 0.073 | 0.202 | Anesthetic general | 0.157 0.106 CID_105022 0.157 0.106 CID_104988 0.161 0.102 CID_104936 | ||
| 0.162 | 0.033 | 0.162 | Aminopeptidase B inhibitor | 0.093 0.07 CID_107705 0.134 0.045 CID_105022 0.134 0.045 CID_104988 0.132 0.046 CID_104936 | ||
| 0.149 | 0.021 | 0.149 | Phosphodiesterase 7B inhibitor | |||
| 0.149 | 0.023 | 0.17 | Androgen antagonist | 0.149 0.023 CID_107705 0.17 0.018 CID_105022 0.17 0.018 CID_104988 0.15 0.023 CID_104936 | CID_104988 | |
| 0.13 | 0.005 | 0.13 | AMPA 2 receptor antagonist | 0.058 0.009 CID_105022 0.058 0.009 CID_104988 0.056 0.01 CID_104936 | ||
| 0.135 | 0.01 | 0.135 | NMDA receptor agonist | 0.067 0.039 CID_107705 0.108 0.017 CID_105022 0.108 0.017 CID_104988 0.11 0.016 CID_104936 | ||
| 0.17 | 0.047 | 0.188 | Cell wall synthesis inhibitor | 0.188 0.035 CID_105022 0.188 0.035 CID_104988 0.18 0.04 CID_104936 | CID_104988 | |
| 0.125 | 0.003 | 0.125 | Kainate receptor 3 antagonist | 0.025 0.007 CID_107705 0.033 0.005 CID_105022 0.033 0.005 CID_104988 0.033 0.005 CID_104936 | ||
| 0.132 | 0.013 | 0.134 | Glycine receptor antagonist | 0.134 0.012 CID_107705 0.111 0.024 CID_105022 0.111 0.024 CID_104988 0.117 0.019 CID_104936 | CID_107705 | |
| 0.153 | 0.035 | 0.156 | Ca2+-transporting ATPase inhibitor | 0.147 0.049 CID_107705 0.155 0.033 CID_105022 0.155 0.033 CID_104988 0.156 0.031 CID_104936 | CID_104936 | |
| 0.195 | 0.077 | 0.195 | Death-associated protein kinase 3 inhibitor | 0.148 0.125 CID_105022 0.148 0.125 CID_104988 0.159 0.109 CID_104936 | ||
| 0.214 | 0.096 | 0.214 | Neuropeptide Y2 antagonist | 0.18 0.16 CID_105022 0.18 0.16 CID_104988 | ||
| 0.14 | 0.024 | 0.14 | Potassium channel activator | 0.081 0.073 CID_107705 0.134 0.026 CID_105022 0.134 0.026 CID_104988 0.125 0.03 CID_104936 | ||
| 0.121 | 0.005 | 0.121 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.092 0.02 CID_107705 0.089 0.023 CID_105022 0.089 0.023 CID_104988 0.091 0.021 CID_104936 | ||
| 0.136 | 0.021 | 0.136 | Phosphofructokinase-1 inhibitor | 0.11 0.028 CID_107705 0.135 0.021 CID_105022 0.135 0.021 CID_104988 0.124 0.024 CID_104936 | ||
| 0.144 | 0.028 | 0.155 | Multidrug resistance-associated protein 1 inhibitor | 0.136 0.033 CID_105022 0.136 0.033 CID_104988 0.155 0.023 CID_104936 | CID_104936 | |
| 0.155 | 0.042 | 0.164 | Antibacterial (Helicobacter pylori) | 0.164 0.036 CID_105022 0.164 0.036 CID_104988 0.155 0.042 CID_104936 | CID_104988 | |
| 0.147 | 0.034 | 0.159 | DNA repair enzyme inhibitor | 0.108 0.103 CID_107705 0.159 0.024 CID_105022 0.159 0.024 CID_104988 0.156 0.027 CID_104936 | CID_104988 | |
| 0.138 | 0.025 | 0.138 | Factor V inhibitor | 0.109 0.052 CID_107705 0.109 0.052 CID_105022 0.109 0.052 CID_104988 0.116 0.043 CID_104936 | ||
| 0.163 | 0.05 | 0.163 | MAP kinase 3 inhibitor | 0.135 0.094 CID_105022 0.135 0.094 CID_104988 0.136 0.092 CID_104936 | ||
| 0.167 | 0.056 | 0.167 | Thiol protease inhibitor | 0.142 0.078 CID_105022 0.142 0.078 CID_104988 0.141 0.078 CID_104936 | ||
| 0.139 | 0.028 | 0.161 | Breast cancer-resistant protein inhibitor | 0.157 0.021 CID_105022 0.157 0.021 CID_104988 0.161 0.02 CID_104936 | CID_104936 | |
| 0.12 | 0.01 | 0.124 | Androgen agonist | 0.097 0.016 CID_107705 0.124 0.009 CID_105022 0.124 0.009 CID_104988 0.108 0.012 CID_104936 | CID_104988 | |
| 0.166 | 0.057 | 0.23 | Amylase inhibitor | 0.104 0.093 CID_107705 0.23 0.034 CID_105022 0.23 0.034 CID_104988 0.203 0.043 CID_104936 | CID_104988 | |
| 0.117 | 0.01 | 0.117 | NMDA receptor glycine site agonist | 0.064 0.042 CID_107705 0.1 0.017 CID_105022 0.1 0.017 CID_104988 0.101 0.016 CID_104936 | ||
| 0.111 | 0.005 | 0.111 | Glutamate (mGluR4) antagonist | 0.044 0.029 CID_107705 0.085 0.007 CID_105022 0.085 0.007 CID_104988 0.084 0.008 CID_104936 | ||
| 0.11 | 0.005 | 0.11 | Transcription factor RelA inhibitor | 0.09 0.01 CID_107705 0.108 0.005 CID_105022 0.108 0.005 CID_104988 0.107 0.005 CID_104936 | ||
| 0.141 | 0.037 | 0.149 | CC chemokine 6 receptor antagonist | 0.149 0.023 CID_105022 0.149 0.023 CID_104988 0.143 0.033 CID_104936 | CID_104988 | |
| 0.143 | 0.039 | 0.143 | 5 Hydroxytryptamine 3A agonist | 0.099 0.077 CID_105022 0.099 0.077 CID_104988 | ||
| 0.119 | 0.017 | 0.119 | Sphingosine 1-phosphate receptor 4 agonist | 0.075 0.04 CID_105022 0.075 0.04 CID_104988 0.07 0.045 CID_104936 | ||
| 0.123 | 0.021 | 0.13 | Glutathione S-transferase inhibitor | 0.082 0.059 CID_107705 0.13 0.018 CID_105022 0.13 0.018 CID_104988 0.108 0.031 CID_104936 | CID_104988 | |
| 0.116 | 0.016 | 0.116 | Argininosuccinate synthase inhibitor | 0.061 0.036 CID_107705 0.085 0.023 CID_105022 0.085 0.023 CID_104988 0.085 0.023 CID_104936 | ||
| 0.184 | 0.084 | 0.184 | Focal adhesion kinase 2 inhibitor | 0.145 0.138 CID_104936 | ||
| 0.138 | 0.038 | 0.154 | Caspase 3 inhibitor | 0.153 0.026 CID_105022 0.153 0.026 CID_104988 0.154 0.025 CID_104936 | CID_104936 | |
| 0.151 | 0.052 | 0.151 | Pregnane X receptor agonist | 0.133 0.091 CID_107705 0.123 0.119 CID_105022 0.123 0.119 CID_104988 | ||
| 0.116 | 0.018 | 0.126 | GABA aminotransferase inhibitor | 0.126 0.014 CID_105022 0.126 0.014 CID_104988 0.114 0.019 CID_104936 | CID_104988 | |
| 0.104 | 0.007 | 0.104 | Kainate receptor antagonist | 0.038 0.031 CID_107705 0.078 0.01 CID_105022 0.078 0.01 CID_104988 0.071 0.012 CID_104936 | ||
| 0.124 | 0.027 | 0.124 | Histamine N-methyltransferase inhibitor | 0.099 0.046 CID_105022 0.099 0.046 CID_104988 0.094 0.052 CID_104936 | ||
| 0.123 | 0.027 | 0.123 | Lanosterol 14 alpha demethylase inhibitor | 0.086 0.08 CID_107705 0.091 0.07 CID_105022 0.091 0.07 CID_104988 | ||
| 0.1 | 0.005 | 0.1 | Calcium channel P-type blocker | 0.075 0.02 CID_107705 0.083 0.013 CID_105022 0.083 0.013 CID_104988 0.078 0.017 CID_104936 | ||
| 0.107 | 0.012 | 0.119 | GABA B receptor agonist | 0.073 0.06 CID_107705 0.119 0.008 CID_105022 0.119 0.008 CID_104988 0.109 0.011 CID_104936 | CID_104988 | |
| 0.137 | 0.042 | 0.137 | Calcium channel (voltage-sensitive) blocker | |||
| 0.172 | 0.079 | 0.172 | LIM domain kinase 1 inhibitor | 0.139 0.11 CID_105022 0.139 0.11 CID_104988 0.147 0.1 CID_104936 | ||
| 0.153 | 0.06 | 0.153 | Cytokine production inhibitor | 0.138 0.072 CID_105022 0.138 0.072 CID_104988 0.127 0.082 CID_104936 | ||
| 0.114 | 0.022 | 0.114 | 3C-Like protease (SARS coronavirus) inhibitor | 0.079 0.072 CID_107705 0.097 0.036 CID_105022 0.097 0.036 CID_104988 0.098 0.035 CID_104936 | ||
| 0.103 | 0.012 | 0.118 | NMDA 2A receptor antagonist | 0.118 0.01 CID_105022 0.118 0.01 CID_104988 0.114 0.01 CID_104936 | CID_104988 | |
| 0.096 | 0.005 | 0.096 | Glutamate (mGluR group III) antagonist | 0.056 0.015 CID_107705 0.069 0.01 CID_105022 0.069 0.01 CID_104988 0.069 0.01 CID_104936 | ||
| 0.132 | 0.042 | 0.204 | Alpha 2c adrenoreceptor antagonist | 0.204 0.017 CID_107705 0.116 0.053 CID_105022 0.116 0.053 CID_104988 0.119 0.05 CID_104936 | CID_107705 | |
| 0.094 | 0.005 | 0.094 | Thymidylate synthase inhibitor | 0.057 0.02 CID_107705 0.087 0.005 CID_105022 0.087 0.005 CID_104988 0.083 0.006 CID_104936 | ||
| 0.115 | 0.026 | 0.115 | Glutamate release inhibitor | 0.101 0.04 CID_107705 0.104 0.037 CID_105022 0.104 0.037 CID_104988 0.096 0.049 CID_104936 | ||
| 0.114 | 0.025 | 0.115 | Glutamate dehydrogenase inhibitor | 0.08 0.045 CID_107705 0.115 0.024 CID_105022 0.115 0.024 CID_104988 0.114 0.025 CID_104936 | CID_104988 | |
| 0.162 | 0.074 | 0.178 | Arachidonic acid antagonist | 0.162 0.075 CID_107705 0.178 0.056 CID_105022 0.178 0.056 CID_104988 0.163 0.073 CID_104936 | CID_104988 | |
| 0.183 | 0.094 | 0.255 | Interleukin antagonist | 0.255 0.06 CID_107705 0.227 0.071 CID_105022 0.227 0.071 CID_104988 0.246 0.063 CID_104936 | CID_107705 | |
| 0.112 | 0.024 | 0.137 | Glutamate decarboxylase inhibitor | 0.065 0.062 CID_107705 0.137 0.016 CID_105022 0.137 0.016 CID_104988 0.13 0.018 CID_104936 | CID_104988 | |
| 0.123 | 0.037 | 0.125 | GABA C receptor rho-1 antagonist | 0.122 0.038 CID_105022 0.122 0.038 CID_104988 0.125 0.036 CID_104936 | CID_104936 | |
| 0.115 | 0.029 | 0.115 | CYP2A6 inhibitor | 0.066 0.065 CID_104936 | ||
| 0.156 | 0.072 | 0.257 | Protein-tyrosine phosphatase inhibitor | 0.148 0.08 CID_107705 0.257 0.029 CID_105022 0.257 0.029 CID_104988 0.255 0.029 CID_104936 | CID_104988 | |
| 0.122 | 0.038 | 0.135 | Anabolic | 0.094 0.072 CID_107705 0.135 0.027 CID_105022 0.135 0.027 CID_104988 0.128 0.032 CID_104936 | CID_104988 | |
| 0.1 | 0.017 | 0.117 | Purinergic P2X1 antagonist | 0.064 0.038 CID_107705 0.117 0.012 CID_105022 0.117 0.012 CID_104988 0.104 0.015 CID_104936 | CID_104988 | |
| 0.088 | 0.005 | 0.088 | Kainate receptor 2 antagonist | 0.064 0.01 CID_105022 0.064 0.01 CID_104988 0.058 0.012 CID_104936 | ||
| 0.216 | 0.134 | 0.216 | Insulysin inhibitor | |||
| 0.103 | 0.021 | 0.145 | Aromatase inhibitor | 0.098 0.022 CID_107705 0.141 0.014 CID_105022 0.141 0.014 CID_104988 0.145 0.014 CID_104936 | CID_104936 | |
| 0.114 | 0.032 | 0.114 | NADH dehydrogenase inhibitor | 0.094 0.051 CID_107705 0.113 0.033 CID_105022 0.113 0.033 CID_104988 0.099 0.045 CID_104936 | ||
| 0.225 | 0.144 | 0.26 | Cholesterol antagonist | 0.208 0.157 CID_107705 0.26 0.118 CID_105022 0.26 0.118 CID_104988 0.219 0.149 CID_104936 | CID_104988 | |
| 0.127 | 0.046 | 0.136 | GABA C receptor antagonist | 0.133 0.041 CID_105022 0.133 0.041 CID_104988 0.136 0.039 CID_104936 | CID_104936 | |
| 0.102 | 0.022 | 0.296 | T cell inhibitor | 0.296 0.005 CID_107705 0.119 0.015 CID_105022 0.119 0.015 CID_104988 0.117 0.015 CID_104936 | CID_107705 | |
| 0.106 | 0.028 | 0.106 | Granulocyte macrophage colony stimulating factor agonist | 0.096 0.041 CID_105022 0.096 0.041 CID_104988 0.095 0.042 CID_104936 | ||
| 0.079 | 0.004 | 0.079 | Nerve growth factor antagonist | 0.047 0.022 CID_107705 0.057 0.012 CID_105022 0.057 0.012 CID_104988 0.06 0.009 CID_104936 | ||
| 0.109 | 0.034 | 0.139 | Carbonic anhydrase XIII inhibitor | 0.139 0.024 CID_105022 0.139 0.024 CID_104988 0.105 0.035 CID_104936 | CID_104988 | |
| 0.12 | 0.047 | 0.137 | Carbonic anhydrase XV inhibitor | 0.137 0.036 CID_105022 0.137 0.036 CID_104988 0.111 0.054 CID_104936 | CID_104988 | |
| 0.081 | 0.008 | 0.081 | Potassium channel (Inward rectifier) activator | 0.063 0.016 CID_107705 0.061 0.019 CID_105022 0.061 0.019 CID_104988 0.06 0.019 CID_104936 | ||
| 0.088 | 0.015 | 0.103 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.098 0.011 CID_105022 0.098 0.011 CID_104988 0.103 0.009 CID_104936 | CID_104936 | |
| 0.16 | 0.087 | 0.178 | Phospholipase C inhibitor | 0.178 0.063 CID_105022 0.178 0.063 CID_104988 0.174 0.068 CID_104936 | CID_104988 | |
| 0.138 | 0.065 | 0.138 | Nav1.2 sodium channel blocker | 0.109 0.097 CID_105022 0.109 0.097 CID_104988 0.111 0.094 CID_104936 | ||
| 0.078 | 0.007 | 0.078 | GABA B receptor antagonist | 0.053 0.017 CID_107705 0.064 0.01 CID_105022 0.064 0.01 CID_104988 0.066 0.01 CID_104936 | ||
| 0.141 | 0.069 | 0.141 | Histone deacetylase SIRT1 inhibitor | 0.11 0.104 CID_107705 0.128 0.082 CID_105022 0.128 0.082 CID_104988 0.12 0.092 CID_104936 | ||
| 0.086 | 0.014 | 0.086 | Potassium channel intermediate-conductance Ca-activated blocker | 0.057 0.047 CID_104936 | ||
| 0.078 | 0.007 | 0.078 | AMPA 4 receptor antagonist | 0.052 0.014 CID_105022 0.052 0.014 CID_104988 0.052 0.014 CID_104936 | ||
| 0.09 | 0.019 | 0.09 | Glutamate (mGluR1) antagonist | |||
| 0.078 | 0.007 | 0.078 | Potassium channel (ATP-sensitive) activator | 0.06 0.016 CID_107705 0.058 0.018 CID_105022 0.058 0.018 CID_104988 0.057 0.019 CID_104936 | ||
| 0.213 | 0.143 | 0.222 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.189 0.17 CID_105022 0.189 0.17 CID_104988 0.222 0.134 CID_104936 | CID_104936 | |
| 0.091 | 0.023 | 0.091 | Carbonic anhydrase IX inhibitor | 0.051 0.042 CID_105022 0.051 0.042 CID_104988 | ||
| 0.083 | 0.015 | 0.083 | Botulinum neurotoxin type A inhibitor | 0.053 0.05 CID_107705 0.083 0.015 CID_105022 0.083 0.015 CID_104988 0.079 0.017 CID_104936 | ||
| 0.14 | 0.073 | 0.142 | Heat shock protein 70 antagonist | 0.142 0.069 CID_105022 0.142 0.069 CID_104988 0.136 0.091 CID_104936 | CID_104988 | |
| 0.113 | 0.047 | 0.113 | Sphingomyelinase inhibitor | 0.093 0.068 CID_107705 0.098 0.062 CID_105022 0.098 0.062 CID_104988 0.09 0.072 CID_104936 | ||
| 0.133 | 0.068 | 0.133 | Sphingosine 1-phosphate receptor 2 antagonist | 0.115 0.11 CID_105022 0.115 0.11 CID_104988 0.124 0.086 CID_104936 | ||
| 0.095 | 0.03 | 0.099 | Prostaglandin-E synthase inhibitor | 0.099 0.027 CID_105022 0.099 0.027 CID_104988 0.087 0.034 CID_104936 | CID_104988 | |
| 0.087 | 0.023 | 0.087 | Carbonic anhydrase XII inhibitor | 0.063 0.031 CID_105022 0.063 0.031 CID_104988 0.044 0.043 CID_104936 | ||
| 0.069 | 0.005 | 0.069 | Glutamate (mGluR8) agonist | 0.049 0.012 CID_107705 0.059 0.007 CID_105022 0.059 0.007 CID_104988 0.054 0.009 CID_104936 | ||
| 0.073 | 0.009 | 0.073 | AICAR transformylase inhibitor | 0.045 0.028 CID_107705 0.068 0.01 CID_105022 0.068 0.01 CID_104988 0.059 0.015 CID_104936 | ||
| 0.089 | 0.027 | 0.089 | Vanilloid 4 agonist | 0.071 0.062 CID_105022 0.071 0.062 CID_104988 0.076 0.049 CID_104936 | ||
| 0.213 | 0.15 | 0.264 | Thyroid hormone antagonist | 0.264 0.114 CID_105022 0.264 0.114 CID_104988 0.241 0.129 CID_104936 | CID_104988 | |
| 0.084 | 0.021 | 0.084 | Caspase 9 inhibitor | 0.065 0.038 CID_105022 0.065 0.038 CID_104988 0.063 0.042 CID_104936 | ||
| 0.078 | 0.016 | 0.097 | Plasminogen activator inhibitor antagonist | 0.097 0.011 CID_105022 0.097 0.011 CID_104988 0.086 0.013 CID_104936 | CID_104988 | |
| 0.092 | 0.029 | 0.092 | Carbonic anhydrase VA inhibitor | 0.086 0.032 CID_105022 0.086 0.032 CID_104988 0.069 0.047 CID_104936 | ||
| 0.075 | 0.013 | 0.081 | Dihydroorotate oxidase inhibitor | 0.081 0.01 CID_105022 0.081 0.01 CID_104988 0.069 0.018 CID_104936 | CID_104988 | |
| 0.219 | 0.157 | 0.301 | Apoptosis antagonist | 0.301 0.085 CID_107705 0.301 0.085 CID_105022 0.301 0.085 CID_104988 0.287 0.094 CID_104936 | CID_104988 | |
| 0.069 | 0.008 | 0.069 | Alpha 1d adrenoreceptor agonist | 0.037 0.029 CID_105022 0.037 0.029 CID_104988 0.039 0.026 CID_104936 | ||
| 0.12 | 0.059 | 0.131 | Transcription factor STAT6 inhibitor | 0.131 0.043 CID_105022 0.131 0.043 CID_104988 0.114 0.07 CID_104936 | CID_104988 | |
| 0.1 | 0.039 | 0.133 | Carbonic anhydrase VI inhibitor | 0.133 0.025 CID_105022 0.133 0.025 CID_104988 0.106 0.036 CID_104936 | CID_104988 | |
| 0.201 | 0.14 | 0.361 | Lipoxygenase inhibitor | 0.176 0.169 CID_107705 0.361 0.048 CID_105022 0.361 0.048 CID_104988 0.353 0.05 CID_104936 | CID_104988 | |
| 0.098 | 0.037 | 0.098 | Histamine H2 receptor antagonist | |||
| 0.139 | 0.078 | 0.139 | CDC-like kinase 1 inhibitor | |||
| 0.083 | 0.023 | 0.157 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.058 0.042 CID_107705 0.157 0.006 CID_105022 0.157 0.006 CID_104988 0.14 0.008 CID_104936 | CID_104988 | |
| 0.064 | 0.005 | 0.064 | Kainate receptor agonist | 0.051 0.013 CID_107705 0.056 0.009 CID_105022 0.056 0.009 CID_104988 0.054 0.01 CID_104936 | ||
| 0.072 | 0.013 | 0.072 | Lysophosphatidic acid 3 receptor antagonist | 0.052 0.032 CID_107705 0.067 0.016 CID_105022 0.067 0.016 CID_104988 0.067 0.017 CID_104936 | ||
| 0.14 | 0.082 | 0.14 | Neuropeptide Y1 antagonist | |||
| 0.123 | 0.065 | 0.308 | Topoisomerase II inhibitor | 0.308 0.017 CID_105022 0.308 0.017 CID_104988 0.308 0.017 CID_104936 | CID_104936 | |
| 0.073 | 0.016 | 0.073 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.081 | 0.024 | 0.081 | Exportin-1 inhibitor | 0.078 0.028 CID_107705 | ||
| 0.088 | 0.031 | 0.088 | Carbonic anhydrase inhibitor | 0.06 0.046 CID_105022 0.06 0.046 CID_104988 | ||
| 0.078 | 0.022 | 0.078 | MDM2 inhibitor | 0.065 0.054 CID_107705 0.063 0.062 CID_105022 0.063 0.062 CID_104988 0.065 0.054 CID_104936 | ||
| 0.062 | 0.007 | 0.062 | Phenylethanolamine N methyltransferase inhibitor | 0.038 0.033 CID_107705 0.05 0.014 CID_105022 0.05 0.014 CID_104988 0.048 0.017 CID_104936 | ||
| 0.071 | 0.016 | 0.071 | Ryanodine receptor antagonist | 0.068 0.021 CID_105022 0.068 0.021 CID_104988 0.067 0.022 CID_104936 | ||
| 0.072 | 0.018 | 0.072 | Bcl-xL inhibitor | 0.06 0.04 CID_107705 0.07 0.02 CID_105022 0.07 0.02 CID_104988 0.068 0.023 CID_104936 | ||
| 0.086 | 0.033 | 0.086 | Carbonic anhydrase V inhibitor | 0.08 0.035 CID_105022 0.08 0.035 CID_104988 0.062 0.051 CID_104936 | ||
| 0.161 | 0.108 | 0.161 | I kappa B kinase epsilon inhibitor | 0.138 0.134 CID_105022 0.138 0.134 CID_104988 | ||
| 0.067 | 0.014 | 0.067 | Fructose-1,6-bisphosphatase inhibitor | 0.048 0.028 CID_105022 0.048 0.028 CID_104988 0.047 0.028 CID_104936 | ||
| 0.059 | 0.006 | 0.059 | AMPA 3 receptor antagonist | 0.04 0.014 CID_105022 0.04 0.014 CID_104988 0.04 0.014 CID_104936 | ||
| 0.06 | 0.007 | 0.06 | Integrin alpha2 antagonist | 0.035 0.029 CID_107705 0.039 0.022 CID_105022 0.039 0.022 CID_104988 0.036 0.027 CID_104936 | ||
| 0.121 | 0.069 | 0.121 | Histone deacetylase class III inhibitor | 0.1 0.09 CID_105022 0.1 0.09 CID_104988 0.112 0.078 CID_104936 | ||
| 0.071 | 0.018 | 0.071 | Aconitate hydratase inhibitor | 0.05 0.038 CID_105022 0.05 0.038 CID_104988 0.053 0.034 CID_104936 | ||
| 0.113 | 0.061 | 0.113 | Acetylcholine release stimulant | |||
| 0.058 | 0.007 | 0.058 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.039 0.012 CID_107705 0.038 0.013 CID_105022 0.038 0.013 CID_104988 0.039 0.012 CID_104936 | ||
| 0.202 | 0.152 | 0.246 | Thyroid hormone beta antagonist | 0.246 0.121 CID_105022 0.246 0.121 CID_104988 0.225 0.135 CID_104936 | CID_104988 | |
| 0.086 | 0.035 | 0.086 | Sphingosine 1-phosphate receptor antagonist | 0.071 0.067 CID_105022 0.071 0.067 CID_104988 0.073 0.064 CID_104936 | ||
| 0.066 | 0.016 | 0.066 | Aldosterone antagonist | 0.043 0.042 CID_107705 | ||
| 0.059 | 0.009 | 0.059 | AMPA 1 receptor antagonist | 0.038 0.015 CID_105022 0.038 0.015 CID_104988 0.034 0.018 CID_104936 | ||
| 0.149 | 0.102 | 0.151 | Tumour necrosis factor antagonist | 0.149 0.102 CID_107705 0.151 0.099 CID_105022 0.151 0.099 CID_104988 | CID_104988 | |
| 0.057 | 0.01 | 0.057 | Potassium channel Kv1.1 blocker | |||
| 0.082 | 0.036 | 0.095 | Phenylalanine 4-hydroxylase inhibitor | 0.095 0.028 CID_105022 0.095 0.028 CID_104988 0.093 0.029 CID_104936 | CID_104988 | |
| 0.074 | 0.027 | 0.074 | Carbonic anhydrase I inhibitor | 0.047 0.045 CID_105022 0.047 0.045 CID_104988 | ||
| 0.179 | 0.133 | 0.215 | Immunostimulant | 0.155 0.151 CID_107705 0.215 0.111 CID_105022 0.215 0.111 CID_104988 0.213 0.112 CID_104936 | CID_104988 | |
| 0.051 | 0.005 | 0.051 | NMDA receptor glycine site antagonist | 0.043 0.007 CID_105022 0.043 0.007 CID_104988 0.043 0.007 CID_104936 | ||
| 0.077 | 0.032 | 0.077 | Glutamate (mGluR7) antagonist | 0.064 0.054 CID_107705 | ||
| 0.14 | 0.096 | 0.2 | Melanin inhibitor | 0.2 0.041 CID_105022 0.2 0.041 CID_104988 0.182 0.05 CID_104936 | CID_104988 | |
| 0.243 | 0.199 | 0.33 | MAP kinase kinase 6 inhibitor | 0.313 0.123 CID_105022 0.313 0.123 CID_104988 0.33 0.109 CID_104936 | CID_104936 | |
| 0.07 | 0.026 | 0.07 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.05 0.049 CID_107705 0.053 0.044 CID_105022 0.053 0.044 CID_104988 0.056 0.039 CID_104936 | ||
| 0.059 | 0.015 | 0.059 | Purinergic P2X4 antagonist | 0.051 0.023 CID_105022 0.051 0.023 CID_104988 0.052 0.023 CID_104936 | ||
| 0.072 | 0.029 | 0.072 | Carbonic anhydrase II inhibitor | 0.05 0.044 CID_105022 0.05 0.044 CID_104988 | ||
| 0.069 | 0.026 | 0.069 | Ornithine carbamoyltransferase inhibitor | 0.05 0.04 CID_105022 0.05 0.04 CID_104988 0.049 0.04 CID_104936 | ||
| 0.073 | 0.03 | 0.073 | Nitric oxide donor | 0.064 0.041 CID_105022 0.064 0.041 CID_104988 0.062 0.045 CID_104936 | ||
| 0.12 | 0.078 | 0.142 | Cyclooxygenase 3 inhibitor | 0.142 0.055 CID_105022 0.142 0.055 CID_104988 0.115 0.083 CID_104936 | CID_104988 | |
| 0.064 | 0.023 | 0.064 | Carbonic anhydrase XIV inhibitor | 0.061 0.024 CID_105022 0.061 0.024 CID_104988 0.053 0.03 CID_104936 | ||
| 0.063 | 0.023 | 0.063 | Alpha-mannosidase inhibitor | 0.055 0.034 CID_107705 0.055 0.035 CID_105022 0.055 0.035 CID_104988 0.054 0.036 CID_104936 | ||
| 0.054 | 0.013 | 0.054 | GABA uptake inhibitor | 0.043 0.022 CID_105022 0.043 0.022 CID_104988 0.044 0.021 CID_104936 | ||
| 0.062 | 0.022 | 0.062 | Potassium channel (Inward rectifier) blocker | 0.045 0.042 CID_107705 | ||
| 0.046 | 0.006 | 0.046 | Kainate receptor 1 antagonist | 0.025 0.013 CID_105022 0.025 0.013 CID_104988 0.023 0.013 CID_104936 | ||
| 0.097 | 0.057 | 0.097 | Bile acid receptor antagonist | 0.097 0.055 CID_105022 0.097 0.055 CID_104988 0.092 0.068 CID_104936 | ||
| 0.15 | 0.111 | 0.15 | Ca2+/calmodulin-dependent protein kinase inhibitor | |||
| 0.077 | 0.038 | 0.179 | Potassium channel large-conductance Ca-activated activator | 0.179 0.008 CID_105022 0.179 0.008 CID_104988 0.176 0.008 CID_104936 | CID_104988 | |
| 0.099 | 0.06 | 0.183 | Xanthine oxidase inhibitor | 0.183 0.023 CID_105022 0.183 0.023 CID_104988 0.157 0.032 CID_104936 | CID_104988 | |
| 0.051 | 0.012 | 0.051 | Heme oxygenase inhibitor | 0.042 0.033 CID_105022 0.042 0.033 CID_104988 0.041 0.038 CID_104936 | ||
| 0.061 | 0.023 | 0.061 | Immunoglobulin Fc receptor antagonist | |||
| 0.059 | 0.021 | 0.059 | Sodium/calcium exchanger inhibitor | 0.046 0.044 CID_107705 | ||
| 0.066 | 0.029 | 0.096 | Fatty acid synthase inhibitor | 0.068 0.027 CID_107705 0.096 0.012 CID_105022 0.096 0.012 CID_104988 0.086 0.016 CID_104936 | CID_104988 | |
| 0.067 | 0.03 | 0.067 | Carbonic anhydrase VB inhibitor | 0.062 0.034 CID_105022 0.062 0.034 CID_104988 0.049 0.046 CID_104936 | ||
| 0.084 | 0.047 | 0.085 | Na+ K+ transporting ATPase inhibitor | 0.067 0.063 CID_107705 0.084 0.046 CID_105022 0.084 0.046 CID_104988 0.085 0.046 CID_104936 | CID_104936 | |
| 0.157 | 0.12 | 0.157 | Anticonvulsant | |||
| 0.056 | 0.021 | 0.056 | Collagenase inhibitor | 0.046 0.041 CID_105022 0.046 0.041 CID_104988 | ||
| 0.055 | 0.019 | 0.055 | Benzodiazepine antagonist | |||
| 0.099 | 0.064 | 0.118 | Protein kinase (CK2) inhibitor | 0.117 0.05 CID_105022 0.117 0.05 CID_104988 0.118 0.049 CID_104936 | CID_104936 | |
| 0.124 | 0.089 | 0.124 | Nav1.6 sodium channel blocker | |||
| 0.068 | 0.034 | 0.082 | Alpha 2 adrenoreceptor agonist | 0.082 0.022 CID_107705 0.055 0.05 CID_104936 | CID_107705 | |
| 0.081 | 0.047 | 0.135 | Alpha 2a adrenoreceptor antagonist | 0.135 0.026 CID_107705 0.07 0.058 CID_105022 0.07 0.058 CID_104988 0.073 0.055 CID_104936 | CID_107705 | |
| 0.039 | 0.006 | 0.039 | Integrin alpha2beta1 antagonist | 0.025 0.022 CID_105022 0.025 0.022 CID_104988 | ||
| 0.132 | 0.1 | 0.132 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.055 | 0.023 | 0.055 | Oleamide hydrolase inhibitor | |||
| 0.053 | 0.022 | 0.053 | Mannosidase inhibitor | 0.044 0.034 CID_107705 0.044 0.033 CID_105022 0.044 0.033 CID_104988 0.042 0.036 CID_104936 | ||
| 0.036 | 0.005 | 0.036 | Protease (Human cytomegalovirus) inhibitor | |||
| 0.054 | 0.024 | 0.054 | Glucose-6-phosphate isomerase inhibitor | 0.05 0.03 CID_105022 0.05 0.03 CID_104988 0.049 0.031 CID_104936 | ||
| 0.048 | 0.018 | 0.048 | Dihydropteroate synthase inhibitor | 0.043 0.023 CID_105022 0.043 0.023 CID_104988 0.039 0.028 CID_104936 | ||
| 0.06 | 0.03 | 0.06 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.1 | 0.07 | 0.22 | Topoisomerase I inhibitor | 0.22 0.022 CID_105022 0.22 0.022 CID_104988 0.212 0.024 CID_104936 | CID_104988 | |
| 0.07 | 0.04 | 0.07 | Glutamate (mGluR6) antagonist | |||
| 0.034 | 0.005 | 0.034 | Complement factor 1s inhibitor | 0.026 0.016 CID_105022 0.026 0.016 CID_104988 0.025 0.018 CID_104936 | ||
| 0.069 | 0.04 | 0.185 | HIV-1 integrase (3'-Processing) inhibitor | 0.108 0.023 CID_107705 0.185 0.011 CID_105022 0.185 0.011 CID_104988 0.182 0.011 CID_104936 | CID_104988 | |
| 0.15 | 0.121 | 0.15 | MAP kinase kinase 2 inhibitor | |||
| 0.082 | 0.053 | 0.082 | Phosphodiesterase 3A inhibitor | |||
| 0.048 | 0.021 | 0.048 | Dihydrofolate reductase inhibitor | |||
| 0.133 | 0.106 | 0.176 | Interferon gamma antagonist | 0.176 0.053 CID_107705 0.156 0.07 CID_105022 0.156 0.07 CID_104988 0.143 0.087 CID_104936 | CID_107705 | |
| 0.129 | 0.103 | 0.132 | Adenylate cyclase stimulant | 0.132 0.096 CID_105022 0.132 0.096 CID_104988 0.128 0.106 CID_104936 | CID_104988 | |
| 0.08 | 0.053 | 0.23 | Topoisomerase II alpha inhibitor | 0.226 0.012 CID_105022 0.226 0.012 CID_104988 0.23 0.012 CID_104936 | CID_104936 | |
| 0.082 | 0.056 | 0.082 | CC chemokine 5 receptor agonist | |||
| 0.065 | 0.039 | 0.065 | Carbamoyl phosphate synthetase inhibitor | 0.053 0.051 CID_105022 0.053 0.051 CID_104988 0.053 0.051 CID_104936 | ||
| 0.064 | 0.038 | 0.064 | Prolactin release inhibitor | 0.063 0.041 CID_105022 0.063 0.041 CID_104988 0.062 0.044 CID_104936 | ||
| 0.064 | 0.039 | 0.169 | HIV-1 integrase (Strand Transfer) inhibitor | 0.062 0.04 CID_107705 0.169 0.011 CID_105022 0.169 0.011 CID_104988 0.169 0.011 CID_104936 | CID_104936 | |
| 0.046 | 0.021 | 0.051 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.051 0.014 CID_105022 0.051 0.014 CID_104988 0.05 0.015 CID_104936 | CID_104988 | |
| 0.094 | 0.07 | 0.094 | Nitric-oxide synthase inhibitor | |||
| 0.071 | 0.046 | 0.071 | Protein kinase C beta inhibitor | 0.065 0.058 CID_104936 | ||
| 0.058 | 0.033 | 0.058 | Glucosylceramidase inhibitor | 0.054 0.039 CID_107705 | ||
| 0.048 | 0.025 | 0.048 | Glutamate (mGluR group III) agonist | |||
| 0.112 | 0.089 | 0.125 | Cyclooxygenase 2 inhibitor | 0.125 0.075 CID_105022 0.125 0.075 CID_104988 0.122 0.078 CID_104936 | CID_104988 | |
| 0.078 | 0.054 | 0.099 | Macrophage migration inhibitory factor inhibitor | 0.099 0.035 CID_105022 0.099 0.035 CID_104988 0.089 0.042 CID_104936 | CID_104988 | |
| 0.044 | 0.021 | 0.044 | Progesterone antagonist | 0.034 0.026 CID_107705 0.041 0.022 CID_105022 0.041 0.022 CID_104988 0.031 0.028 CID_104936 | ||
| 0.169 | 0.146 | 0.21 | Spasmolytic | 0.209 0.112 CID_107705 0.186 0.132 CID_105022 0.186 0.132 CID_104988 0.21 0.111 CID_104936 | CID_104936 | |
| 0.033 | 0.011 | 0.035 | Estrogen-related receptor gamma antagonist | 0.035 0.009 CID_105022 0.035 0.009 CID_104988 0.032 0.012 CID_104936 | CID_104988 | |
| 0.074 | 0.052 | 0.074 | Adenosine A3 receptor antagonist | |||
| 0.03 | 0.008 | 0.03 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.024 0.015 CID_105022 0.024 0.015 CID_104988 0.024 0.015 CID_104936 | ||
| 0.03 | 0.009 | 0.03 | Acid ceramidase inhibitor | |||
| 0.038 | 0.018 | 0.038 | Glutamate (mGluR4) agonist | |||
| 0.025 | 0.006 | 0.053 | Alpha 2a adrenoreceptor agonist | 0.053 0.004 CID_107705 0.017 0.012 CID_105022 0.017 0.012 CID_104988 0.019 0.01 CID_104936 | CID_107705 | |
| 0.071 | 0.052 | 0.134 | Telomerase inhibitor | 0.134 0.023 CID_105022 0.134 0.023 CID_104988 0.121 0.026 CID_104936 | CID_104988 | |
| 0.023 | 0.004 | 0.023 | Human herpes virus 5 capsid protein P40 inhibitor | |||
| 0.042 | 0.023 | 0.042 | TRPM8 blocker | |||
| 0.036 | 0.017 | 0.036 | Methionyl aminopeptidase 1 inhibitor | |||
| 0.085 | 0.066 | 0.085 | Pim-3 kinase inhibitor | |||
| 0.075 | 0.056 | 0.075 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.052 | 0.035 | 0.052 | Phosphodiesterase 7A inhibitor | |||
| 0.062 | 0.044 | 0.062 | Histone deacetylase SIRT3 inhibitor | |||
| 0.022 | 0.005 | 0.022 | Thromboxane A2 agonist | 0.017 0.009 CID_107705 0.016 0.009 CID_105022 0.016 0.009 CID_104988 0.015 0.012 CID_104936 | ||
| 0.042 | 0.025 | 0.052 | Dopamine D5 agonist | 0.052 0.016 CID_105022 0.052 0.016 CID_104988 0.05 0.017 CID_104936 | CID_104988 | |
| 0.037 | 0.021 | 0.037 | Fumarate hydratase inhibitor | |||
| 0.034 | 0.017 | 0.034 | Epoxide hydrolase 1 inhibitor | |||
| 0.054 | 0.038 | 0.062 | DNA helicase inhibitor | 0.062 0.024 CID_105022 0.062 0.024 CID_104988 0.061 0.026 CID_104936 | CID_104988 | |
| 0.108 | 0.092 | 0.144 | Acetylcholinesterase inhibitor | 0.14 0.061 CID_105022 0.14 0.061 CID_104988 0.144 0.059 CID_104936 | CID_104936 | |
| 0.081 | 0.065 | 0.09 | Estrogen-related receptor beta agonist | 0.088 0.044 CID_105022 0.088 0.044 CID_104988 0.09 0.041 CID_104936 | CID_104936 | |
| 0.03 | 0.015 | 0.03 | Kynurenine 3 monooxygenase inhibitor | |||
| 0.093 | 0.078 | 0.093 | Falcipain 3 inhibitor | |||
| 0.054 | 0.038 | 0.054 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.024 | 0.009 | 0.024 | Factor XIII inhibitor | |||
| 0.024 | 0.01 | 0.024 | Imidazoline I1 receptor antagonist | |||
| 0.039 | 0.025 | 0.039 | Factor XIIIa inhibitor | |||
| 0.035 | 0.021 | 0.039 | Purinergic P2Y2 antagonist | 0.035 0.021 CID_105022 0.035 0.021 CID_104988 0.039 0.017 CID_104936 | CID_104936 | |
| 0.042 | 0.029 | 0.042 | Angiotensin AT1 receptor antagonist | |||
| 0.033 | 0.02 | 0.052 | Estrogen-related receptor beta antagonist | 0.052 0.005 CID_105022 0.052 0.005 CID_104988 0.049 0.006 CID_104936 | CID_104988 | |
| 0.064 | 0.052 | 0.096 | Cyclin B3 inhibitor | 0.096 0.03 CID_105022 0.096 0.03 CID_104988 0.085 0.035 CID_104936 | CID_104988 | |
| 0.053 | 0.041 | 0.053 | Thromboxane synthase inhibitor | 0.05 0.047 CID_107705 0.05 0.047 CID_105022 0.05 0.047 CID_104988 0.05 0.049 CID_104936 | ||
| 0.026 | 0.014 | 0.026 | Glutamate (mGluR1) agonist | |||
| 0.061 | 0.049 | 0.061 | Neutrophil collagenase inhibitor | |||
| 0.02 | 0.009 | 0.02 | Potassium channel (Inward rectifier) 11 blocker | 0.017 0.016 CID_105022 0.017 0.016 CID_104988 0.017 0.015 CID_104936 | ||
| 0.068 | 0.057 | 0.068 | Phospholipase D inhibitor | |||
| 0.087 | 0.076 | 0.087 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.022 | 0.011 | 0.022 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.073 | 0.062 | 0.124 | Estrogen receptor alpha antagonist | 0.081 0.047 CID_107705 0.124 0.017 CID_105022 0.124 0.017 CID_104988 0.112 0.021 CID_104936 | CID_104988 | |
| 0.068 | 0.057 | 0.068 | Aminopeptidase I inhibitor | |||
| 0.027 | 0.016 | 0.027 | Complement factor 1r inhibitor | |||
| 0.085 | 0.075 | 0.102 | Protein kinase C zeta inhibitor | 0.097 0.054 CID_105022 0.097 0.054 CID_104988 0.102 0.048 CID_104936 | CID_104936 | |
| 0.027 | 0.017 | 0.027 | Thymidine phosphorylase inhibitor | |||
| 0.084 | 0.075 | 0.094 | Prolactin inhibitor | 0.094 0.062 CID_105022 0.094 0.062 CID_104988 0.094 0.061 CID_104936 | CID_104936 | |
| 0.044 | 0.035 | 0.047 | Carbonic anhydrase VII inhibitor | 0.047 0.032 CID_105022 0.047 0.032 CID_104988 0.041 0.039 CID_104936 | CID_104988 | |
| 0.027 | 0.018 | 0.027 | Thymidine kinase (Herpes simplex virus 1) inhibitor | |||
| 0.026 | 0.017 | 0.026 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.013 | 0.005 | 0.014 | Progesterone receptor A antagonist | 0.014 0.004 CID_107705 | CID_107705 | |
| 0.033 | 0.025 | 0.033 | Free fatty acid receptor 1 antagonist | |||
| 0.022 | 0.014 | 0.022 | Glutaminyl-peptide cyclotransferase inhibitor | |||
| 0.091 | 0.083 | 0.148 | AMP-activated protein kinase stimulant | 0.148 0.029 CID_105022 0.148 0.029 CID_104988 0.142 0.033 CID_104936 | CID_104988 | |
| 0.113 | 0.105 | 0.113 | Activin receptor-like kinase 2 inhibitor | |||
| 0.014 | 0.006 | 0.014 | Glutamate (mGluR6) agonist | 0.013 0.008 CID_105022 0.013 0.008 CID_104988 0.012 0.009 CID_104936 | ||
| 0.099 | 0.092 | 0.148 | Microtubule formation inhibitor | 0.148 0.038 CID_107705 | CID_107705 | |
| 0.04 | 0.034 | 0.04 | Histamine H2 receptor agonist | |||
| 0.095 | 0.088 | 0.095 | Anesthetic local | |||
| 0.047 | 0.04 | 0.054 | Dihydroorotate dehydrogenase inhibitor | 0.054 0.033 CID_105022 0.054 0.033 CID_104988 | CID_104988 | |
| 0.027 | 0.02 | 0.027 | Uridine phosphorylase inhibitor | |||
| 0.059 | 0.053 | 0.137 | CDC25B inhibitor | 0.122 0.01 CID_105022 0.122 0.01 CID_104988 0.137 0.008 CID_104936 | CID_104936 | |
| 0.027 | 0.022 | 0.027 | CDK4/cyclin D3 inhibitor | |||
| 0.209 | 0.204 | 0.346 | 15-Lipoxygenase inhibitor | 0.346 0.102 CID_105022 0.346 0.102 CID_104988 0.34 0.105 CID_104936 | CID_104988 | |
| 0.029 | 0.025 | 0.029 | Endothelial nitric-oxide synthase inhibitor | |||
| 0.038 | 0.035 | 0.038 | Carbonic anhydrase IV inhibitor | |||
| 0.022 | 0.019 | 0.022 | ICAM 1 antagonist | |||
| 0.109 | 0.106 | 0.124 | Protein kinase stimulant | 0.109 0.105 CID_107705 0.124 0.089 CID_105022 0.124 0.089 CID_104988 0.11 0.104 CID_104936 | CID_104988 | |
| 0.033 | 0.03 | 0.033 | 5 Hydroxytryptamine 3B antagonist | |||
| 0.12 | 0.117 | 0.139 | Phospholipase A2 inhibitor | 0.139 0.088 CID_105022 0.139 0.088 CID_104988 0.139 0.087 CID_104936 | CID_104936 | |
| 0.012 | 0.009 | 0.012 | Carbonic anhydrase XI inhibitor | |||
| 0.016 | 0.013 | 0.016 | CDK2/cyclin A3 inhibitor | |||
| 0.033 | 0.03 | 0.033 | Adenosine uptake inhibitor | |||
| 0.041 | 0.038 | 0.041 | Histamine H1 receptor agonist | |||
| 0.09 | 0.088 | 0.11 | Toll-Like receptor 4 antagonist | 0.11 0.055 CID_105022 0.11 0.055 CID_104988 0.09 0.089 CID_104936 | CID_104988 | |
| 0.031 | 0.029 | 0.031 | RNA-directed RNA polymerase inhibitor | 0.031 0.029 CID_105022 0.031 0.029 CID_104988 | ||
| 0.051 | 0.049 | 0.051 | 5 Hydroxytryptamine 7 agonist | |||
| 0.018 | 0.016 | 0.018 | Progesterone receptor B antagonist | |||
| 0.112 | 0.109 | 0.142 | Cyclooxygenase inhibitor | 0.142 0.077 CID_105022 0.142 0.077 CID_104988 0.135 0.083 CID_104936 | CID_104988 | |
| 0.027 | 0.025 | 0.027 | 5 Hydroxytryptamine 6 agonist | |||
| 0.089 | 0.088 | 0.11 | Protein kinase (CK2) alpha inhibitor | 0.11 0.069 CID_105022 0.11 0.069 CID_104988 0.11 0.069 CID_104936 | CID_104936 | |
| 0.03 | 0.029 | 0.03 | Calcium release-activated channel blocker | |||
| 0.035 | 0.034 | 0.035 | Histone deacetylase 8 inhibitor | |||
| 0.048 | 0.047 | 0.086 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.086 0.014 CID_105022 0.086 0.014 CID_104988 0.07 0.021 CID_104936 | CID_104988 | |
| 0.048 | 0.048 | 0.099 | Xanthine dehydrogenase inhibitor | 0.099 0.016 CID_105022 0.099 0.016 CID_104988 0.093 0.018 CID_104936 | CID_104988 | |
| 0.137 | 0.138 | 0.159 | P-glycoprotein inhibitor | 0.157 0.106 CID_105022 0.157 0.106 CID_104988 0.159 0.103 CID_104936 | CID_104936 | |
| 0.044 | 0.046 | 0.098 | Aldose reductase inhibitor | 0.098 0.018 CID_105022 0.098 0.018 CID_104988 0.091 0.02 CID_104936 | CID_104988 | |
| 0.016 | 0.018 | 0.024 | Alpha 2c adrenoreceptor agonist | 0.024 0.007 CID_107705 | CID_107705 | |
| 0.023 | 0.026 | 0.028 | Liver X receptor beta antagonist | 0.028 0.021 CID_105022 0.028 0.021 CID_104988 | CID_104988 | |
| 0.048 | 0.051 | 0.051 | Heparanase inhibitor | 0.051 0.043 CID_107705 | CID_107705 | |
| 0.055 | 0.059 | 0.062 | I kappa B kinase 2 inhibitor | 0.062 0.043 CID_105022 0.062 0.043 CID_104988 | CID_104988 | |
| 0.023 | 0.027 | 0.037 | Sodium/glucose cotransporter 2 inhibitor | 0.037 0.009 CID_107705 0.029 0.014 CID_105022 0.029 0.014 CID_104988 0.027 0.017 CID_104936 | CID_107705 | |
| 0.083 | 0.089 | 0.194 | Monophenol monooxygenase inhibitor | 0.194 0.035 CID_105022 0.194 0.035 CID_104988 0.165 0.042 CID_104936 | CID_104988 | |
| 0.036 | 0.044 | 0.038 | CF transmembrane conductance regulator antagonist | 0.038 0.035 CID_105022 0.038 0.035 CID_104988 0.038 0.033 CID_104936 | CID_104936 | |
| 0.051 | 0.06 | 0.053 | Pregnane X receptor antagonist | 0.053 0.05 CID_104936 | CID_104936 | |
| 0.02 | 0.031 | 0.036 | CC chemokine 8 receptor antagonist | 0.036 0.004 CID_107705 | CID_107705 | |
| 0.07 | 0.081 | 0.092 | Alpha 2 adrenoreceptor antagonist | 0.092 0.054 CID_107705 | CID_107705 | |
| 0.025 | 0.041 | 0.033 | Retinoid X alpha receptor agonist | 0.033 0.027 CID_104936 | CID_104936 | |
| 0.023 | 0.039 | 0.032 | Estrogen-related receptor alpha antagonist | 0.032 0.023 CID_105022 0.032 0.023 CID_104988 | CID_104988 | |
| 0.013 | 0.03 | 0.046 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.046 0.007 CID_105022 0.046 0.007 CID_104988 0.044 0.008 CID_104936 | CID_104988 | |
| 0.021 | 0.038 | 0.029 | Sodium/glucose cotransporter inhibitor | 0.029 0.012 CID_107705 0.024 0.022 CID_105022 0.024 0.022 CID_104988 | CID_107705 | |
| 0.023 | 0.043 | 0.038 | ATP citrate lysase inhibitor | 0.037 0.016 CID_105022 0.037 0.016 CID_104988 0.038 0.014 CID_104936 | CID_104936 | |
| 0.04 | 0.063 | 0.051 | Beta 1 adrenoreceptor antagonist | 0.051 0.045 CID_105022 0.051 0.045 CID_104988 | CID_104988 | |
| 0.093 | 0.117 | 0.12 | Toll-Like receptor 2 antagonist | 0.12 0.078 CID_105022 0.12 0.078 CID_104988 0.106 0.096 CID_104936 | CID_104988 | |
| 0.068 | 0.092 | 0.085 | MAP kinase kinase 7 inhibitor | 0.085 0.033 CID_105022 0.085 0.033 CID_104988 0.079 0.048 CID_104936 | CID_104988 | |
| 0.025 | 0.049 | 0.036 | Inosine monophosphate dehydrogenase inhibitor | 0.036 0.025 CID_104936 | CID_104936 | |
| 0.072 | 0.096 | 0.087 | Interleukin 5 antagonist | 0.078 0.077 CID_105022 0.078 0.077 CID_104988 0.087 0.059 CID_104936 | CID_104936 | |
| 0.05 | 0.074 | 0.059 | Alpha adrenoreceptor agonist | 0.059 0.056 CID_107705 | CID_107705 | |
| 0.073 | 0.098 | 0.11 | ATPase (Vacuolar H+) inhibitor | 0.099 0.042 CID_107705 0.11 0.028 CID_105022 0.11 0.028 CID_104988 0.105 0.033 CID_104936 | CID_104988 | |
| 0.014 | 0.04 | 0.02 | Antibiotic Anthracycline-like | 0.019 0.012 CID_105022 0.019 0.012 CID_104988 0.02 0.012 CID_104936 | CID_104936 | |
| 0.075 | 0.102 | 0.088 | ABCA1 expression enhancer | 0.088 0.07 CID_105022 0.088 0.07 CID_104988 | CID_104988 | |
| 0.049 | 0.077 | 0.065 | Beta adrenoreceptor antagonist | 0.065 0.046 CID_105022 0.065 0.046 CID_104988 0.059 0.058 CID_104936 | CID_104988 | |
| 0.082 | 0.112 | 0.138 | MAO inhibitor | 0.138 0.066 CID_105022 0.138 0.066 CID_104988 0.122 0.073 CID_104936 | CID_104988 | |
| 0.06 | 0.091 | 0.077 | Keratolytic | 0.077 0.053 CID_105022 0.077 0.053 CID_104988 | CID_104988 | |
| 0.062 | 0.094 | 0.105 | MAO B inhibitor | 0.105 0.057 CID_105022 0.105 0.057 CID_104988 0.094 0.063 CID_104936 | CID_104988 | |
| 0.08 | 0.113 | 0.172 | DNA polymerase I inhibitor | 0.172 0.038 CID_105022 0.172 0.038 CID_104988 0.152 0.048 CID_104936 | CID_104988 | |
| 0.103 | 0.138 | 0.118 | Vanilloid 1 agonist | 0.118 0.092 CID_105022 0.118 0.092 CID_104988 0.118 0.093 CID_104936 | CID_104936 | |
| 0.079 | 0.12 | 0.103 | Cholesterol synthesis inhibitor | 0.103 0.083 CID_105022 0.103 0.083 CID_104988 | CID_104988 | |
| 0.052 | 0.097 | 0.059 | Beta 2 adrenoreceptor agonist | 0.059 0.056 CID_105022 0.059 0.056 CID_104988 | CID_104988 | |
| 0.021 | 0.067 | 0.062 | Estradiol 17 beta-dehydrogenase inhibitor | 0.061 0.019 CID_105022 0.061 0.019 CID_104988 0.062 0.019 CID_104936 | CID_104936 | |
| 0.07 | 0.12 | 0.145 | Protein-tyrosine phosphatase 1B inhibitor | 0.092 0.087 CID_107705 0.145 0.047 CID_105022 0.145 0.047 CID_104988 0.144 0.048 CID_104936 | CID_104988 | |
| 0.059 | 0.11 | 0.107 | MAO A inhibitor | 0.107 0.06 CID_105022 0.107 0.06 CID_104988 0.097 0.066 CID_104936 | CID_104988 | |
| 0.029 | 0.087 | 0.143 | Alpha tubulin antagonist | 0.143 0.01 CID_105022 0.143 0.01 CID_104988 0.133 0.011 CID_104936 | CID_104988 | |
| 0.058 | 0.12 | 0.235 | 5-Lipoxygenase inhibitor | 0.235 0.018 CID_105022 0.235 0.018 CID_104988 0.225 0.02 CID_104936 | CID_104988 | |
| 0.033 | 0.095 | 0.049 | Leukotriene B4 antagonist | 0.049 0.047 CID_105022 0.049 0.047 CID_104988 | CID_104988 | |
| 0.122 | 0.186 | 0.205 | Antiamyloidogenic | 0.153 0.144 CID_107705 0.19 0.107 CID_105022 0.19 0.107 CID_104988 0.205 0.096 CID_104936 | CID_104936 | |
| 0.075 | 0.14 | 0.209 | Tubulin antagonist | 0.209 0.034 CID_107705 0.182 0.043 CID_105022 0.182 0.043 CID_104988 0.183 0.043 CID_104936 | CID_107705 | |
| 0.114 | 0.183 | 0.147 | Insulin sensitizer | 0.147 0.138 CID_105022 0.147 0.138 CID_104988 | CID_104988 | |
| 0.125 | 0.2 | 0.371 | Antioxidant | 0.263 0.077 CID_107705 0.371 0.041 CID_105022 0.371 0.041 CID_104988 0.355 0.045 CID_104936 | CID_104988 | |
| 0.039 | 0.115 | 0.078 | Heat shock protein 90 beta antagonist | 0.07 0.028 CID_105022 0.07 0.028 CID_104988 0.078 0.022 CID_104936 | CID_104936 | |
| 0.064 | 0.14 | 0.165 | Estrogen receptor beta antagonist | 0.111 0.044 CID_107705 0.165 0.013 CID_105022 0.165 0.013 CID_104988 0.143 0.017 CID_104936 | CID_104988 | |
| 0.091 | 0.172 | 0.345 | Amyloid beta aggregation inhibitor | 0.146 0.111 CID_107705 0.345 0.036 CID_105022 0.345 0.036 CID_104988 0.342 0.036 CID_104936 | CID_104988 | |
| 0.014 | 0.098 | 0.104 | Estrogen agonist | 0.104 0.016 CID_105022 0.104 0.016 CID_104988 0.086 0.021 CID_104936 | CID_104988 | |
| 0.068 | 0.155 | 0.13 | Cyclooxygenase 1 inhibitor | 0.13 0.071 CID_105022 0.13 0.071 CID_104988 0.124 0.077 CID_104936 | CID_104988 | |
| 0.009 | 0.106 | 0.017 | Antibiotic Tetracycline-like | 0.017 0.007 CID_105022 0.017 0.007 CID_104988 0.016 0.008 CID_104936 | CID_104988 | |
| 0.018 | 0.118 | 0.128 | Beta tubulin antagonist | 0.128 0.016 CID_105022 0.128 0.016 CID_104988 0.121 0.017 CID_104936 | CID_104988 | |
| 0.006 | 0.108 | 0.015 | Thyroid hormone alpha antagonist | 0.015 0.011 CID_105022 0.015 0.011 CID_104988 | CID_104988 | |
| 0.01 | 0.113 | 0.069 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.066 0.009 CID_105022 0.066 0.009 CID_104988 0.069 0.008 CID_104936 | CID_104936 | |
| 0.042 | 0.152 | 0.111 | CDC25A inhibitor | 0.104 0.026 CID_105022 0.104 0.026 CID_104988 0.111 0.022 CID_104936 | CID_104936 | |
| 0.069 | 0.188 | 0.17 | Estrogen antagonist | 0.117 0.061 CID_107705 0.17 0.018 CID_105022 0.17 0.018 CID_104988 0.149 0.023 CID_104936 | CID_104988 | |
| 0.005 | 0.132 | 0.073 | Estrogen receptor beta agonist | 0.073 0.015 CID_105022 0.073 0.015 CID_104988 0.049 0.019 CID_104936 | CID_104988 | |
| 0.1 | 0.228 | 0.367 | Free radical scavenger | 0.225 0.08 CID_107705 0.367 0.035 CID_105022 0.367 0.035 CID_104988 0.35 0.039 CID_104936 | CID_104988 | |
| 0.051 | 0.18 | 0.196 | Chelator | 0.196 0.025 CID_105022 0.196 0.025 CID_104988 0.179 0.028 CID_104936 | CID_104988 | |
| 0.021 | 0.151 | 0.073 | Maillard reaction inhibitor | 0.073 0.028 CID_105022 0.073 0.028 CID_104988 0.06 0.034 CID_104936 | CID_104988 | |
| 0.128 | 0.269 | 0.203 | Peptidyltransferase inhibitor | 0.203 0.095 CID_105022 0.203 0.095 CID_104988 0.187 0.118 CID_104936 | CID_104988 | |
| 0.026 | 0.174 | 0.053 | CXC chemokine 1 receptor antagonist | 0.053 0.032 CID_105022 0.053 0.032 CID_104988 0.051 0.036 CID_104936 | CID_104988 | |
| 0.004 | 0.183 | 0.039 | Estrogen receptor alpha agonist | 0.039 0.021 CID_105022 0.039 0.021 CID_104988 | CID_104988 | |
| 0.02 | 0.217 | 0.059 | Myc inhibitor | 0.059 0.031 CID_107705 | CID_107705 | |
| 0.089 | 0.306 | 0.138 | MAP kinase kinase 4 inhibitor | 0.138 0.09 CID_105022 0.138 0.09 CID_104988 0.136 0.096 CID_104936 | CID_104988 | |
| 0.041 | 0.28 | 0.2 | Lipid peroxidase inhibitor | 0.195 0.044 CID_105022 0.195 0.044 CID_104988 0.2 0.042 CID_104936 | CID_104936 | |
| 0.027 | 0.275 | 0.089 | HIV-1 integrase inhibitor | 0.089 0.032 CID_105022 0.089 0.032 CID_104988 0.087 0.033 CID_104936 | CID_104988 | |
| 0.033 | 0.339 | 0.057 | Heme oxygenase stimulant | 0.057 0.056 CID_105022 0.057 0.056 CID_104988 | CID_104988 | |
| 0.04 | 0.45 | 0.159 | Nitric oxide antagonist | 0.159 0.088 CID_107705 0.147 0.097 CID_105022 0.147 0.097 CID_104988 0.14 0.105 CID_104936 | CID_107705 | |
| 0.052 | 0.483 | 0.301 | Immunosuppressant | 0.301 0.114 CID_107705 | CID_107705 | |
| 0.005 | 0.485 | 0.104 | Antineoplastic antibiotic | 0.104 0.044 CID_107705 | CID_107705 | |
| 0.032 | 0.544 | 0.17 | Platelet adhesion inhibitor | 0.17 0.088 CID_107705 | CID_107705 | |
| 0.021 | 0.561 | 0.393 | Antimitotic | 0.393 0.024 CID_107705 | CID_107705 | |
| 0.004 | 0.558 | 0.064 | Dopamine D5 antagonist | 0.064 0.017 CID_107705 | CID_107705 | |
| 0.029 | 0.634 | 0.137 | Interleukin 2 antagonist | 0.137 0.026 CID_107705 | CID_107705 | |
| 0.013 | 0.677 | 0.132 | Acetylcholine M3 receptor agonist | 0.132 0.029 CID_107705 | CID_107705 | |
| 0.033 | 0.808 | 0.204 | Sodium/bile acid cotransporter inhibitor | 0.204 0.183 CID_105022 0.204 0.183 CID_104988 | CID_104988 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |